Ren Life Sciences Acquires Majority Stake in 53Biologics

McDermott Will & Schulte has advised Ren Life Sciences. Ren Life Sciences has acquired a majority stake in 53Biologics, a contract development and manufacturing organization (CDMO)…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here